Vol. 22 No. 2 (2023)
Clinical Cases

Invasive disease by Streptococcus pneumoniae: a case report and a discussion about the immunization rates in older adults in Brazil

pdf
  • Guilherme Goulart Cabral-Oliveira,
  • Isabelle Chirstine de Moraes Motta,
  • Paula Marcele Afonso Pereira-Ribeiro,
  • Paulo Vieira Damasco,
  • Ana Luiza Mattos-Guaraldi
Guilherme Goulart Cabral-Oliveira
Universidade do Estado do Rio de Janeiro (UERJ)
Bio
Isabelle Chirstine de Moraes Motta
Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
Bio
Paula Marcele Afonso Pereira-Ribeiro
Universidade do Estado do Rio de Janeiro (UERJ)
Bio
Paulo Vieira Damasco
Universidade do Estado do Rio de Janeiro (UERJ); Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
Bio
Ana Luiza Mattos-Guaraldi
Universidade do Estado do Rio de Janeiro (UERJ)
Bio
DOI: https://doi.org/10.12957/bjhbs.2023.77287

Published 2023-11-01

How to Cite

1.
Cabral-Oliveira G, Motta IC, Pereira-Ribeiro P, Damasco P, Mattos-Guaraldi AL. Invasive disease by Streptococcus pneumoniae: a case report and a discussion about the immunization rates in older adults in Brazil. BJHBS [Internet]. 2023 Nov. 1 [cited 2024 Jun. 23];22(2). Available from: https://bjhbs.hupe.uerj.br/bjhbs/article/view/139

Copyright (c) 2023 Brazilian Journal of Health and Biomedical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Invasive disease by Streptococcus pneumoniae has a high mortality rate, principally in old adults and children. This paper presents the progression and prognostic of a case of invasive pneumococcal disease in an elderly woman by vaccinal serotype and promotes a discussion about the monitorization of the vaccinal pneumococcal rate in an old adult population in Brazil.

pdf

Metrics

Metrics Loading ...

References

  1. Marquart ME. Pathogenicity and virulence of Streptococcus pneumoniae: cutting to the chase on proteases. Virulence. 2021;12(1):766-87. doi: 10.1080/21505594.2021.1889812. PMID: 33660565; PMCID: PMC7939560.
  2. de Egea V, Muñoz P, Valerio M, et al. Characteristics and outcome of Streptococcus pneumoniae endocardi-tis in the XXI century: a systematic review of 111 cases (2000–2013). Medicine (Baltimore). 2015;94(39):e1562. doi: 10.1097/MD.0000000000001562. PMID: 26426629; PMCID: PMC4616835.
  3. Domingues K, Marta L, Monteiro I, et al. Native aortic valve pneumococcal endocarditis-fulminant presentation. Rev Bras Ter Inten. 2016;28(1):83-6. doi: 10.5935/0103-507X.20160004. PMID: 27096681; PMCID: PMC4828096.
  4. Brandileone MCC, Almeida SCG, Minamisava R, et al. Distribution of invasive Streptococcus pneumoniae sero-types before and 5 years after the introduction of 10-va-lent pneumococcal conjugate vaccine in Brazil. Vaccine, 2018;36(19):2559–66. doi: 10.1016/j.vaccine.2018.04.010. Epub 2018 Apr 9. PMID: 29650385.
  5. Rakočević R, Shapouran S Pergament KM. Austrian Syndrome - A Devastating Osler's Triad: Case Report and Literature Review. Cureus. 2019;11(4):e4486. doi: 10.7759/cureus.4486. PMID: 31259104; PMCID: PMC6581326.
  6. Daniels CC, Rogers PD, Shelton CM. A Review of Pneu-mococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein Antigens. J Pediatr Pharmacol Ther. 2016;21(1):27-35. doi: 10.5863/1551-6776-21.1.27. PMID: 26997927; PMCID: PMC4778694.
  7. Moreira M, Cintra O, Harriague J, Hausdorff WP, Hoet B. Impact of the introduction of the pneumococcal conjugate vaccine in the Brazilian routine childhood national im-munization program. Vaccine. 2016;34(25):2766-78. doi: 10.1016/j.vaccine.2016.04.006. Epub 2016 Apr 22. PMID: 27113162.
  8. dos Santos SR, Passadore LF, Takagi EH, Fujii CM, Yosh-ioka CRM, Gilio AE et al. Serotype distribution of Strepto-coccus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneu-mococcal conjugate vaccine implementation. Vaccine. 2013;31(51):6150-54. doi: 10.1016/j.vaccine.2013.05.042. Epub 2013 Jun 6. PMID: 23747454.
  9. Neves FPG, Cardoso NT, Cardoso CAA, et al. Direct effect of the 13-valent pneumococcal conjugate vaccine use of pneumococcal colonization among children in Brazil. Vaccine. 2019;37(36):5265-69. doi: 10.1016/j.vac-cine.2019.07.056. Epub 2019 Jul 20. PMID: 31337592.
  10. Pai R, Gertz RE, Beall B. Sequential multiplex PCR ap-proach for determining capsular serotype of Streptococcus pneumoniae isolates. J Clin Microbiol. 2006;44(1):124-31. doi: 10.1128/JCM.44.1.124-131.2006. PMID: 16390959; PMCID: PMC1351965.
  11. Aronin SI, Mukherjee SK, West JC, et al. Review of pneumococcal endocarditis in adults in the penicillin era. Clin Infect Dis. 1998;26(1): 165-171. doi: 10.1086/516279. PMID: 9455526.
  12. Centers for Disease Control and Prevention (CDC). Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000-2012. MMWR Morb Mortal Wkly Rep. 2013;62(16):308–11. PMID: 23615674; PMCID: PMC4604961.
  13. The 2015 ESC Guidelines for the management of infec-tive endocarditis. Eur Heart J. 2015;36(44):3036-37. doi: 10.1093/eurheartj/ehv488. PMID: 26590409.
  14. Ministério da Saúde [internet homepage]. Instrução normativa referente ao calendário nacional de vacinação - 2022. [accessed in January 30 of 2023]. URL: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/c/cal-endario-nacional-de-vacinacao/calendario-vacinal-2022/anexo-normativa-do-calendario-de-vacinacao-atualiza-do_-final-20-09-2022.pdf. (In Portuguese).
  15. Nishikawa AM, Sartori AMC, Mainardi GM, et al. Systemat-ic review of economic evaluations of the 23-valent pneu-mococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older. Vaccine. 2018;36(19):2510-22. doi: 10.1016/j.vaccine.2018.03.070. Epub 2018 Apr 2. PMID: 29618414.

Most read articles by the same author(s)